Cargando…
Management of aromatase inhibitor–induced arthralgia
Aromatase inhibitors (ais) are commonly used as adjuvant treatment in postmenopausal women with hormone receptor–positive early breast cancer. With both steroidal and nonsteroidal ais, ai-induced arthralgia is frequently observed. The mechanism of ai-induced arthralgia remains unknown, and the data...
Autores principales: | Younus, J., Kligman, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826784/ https://www.ncbi.nlm.nih.gov/pubmed/20179809 |
Ejemplares similares
-
Management of hot flashes in women with breast cancer
por: Kligman, L., et al.
Publicado: (2010) -
Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007) -
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients
por: Martinez, Jessica A., et al.
Publicado: (2023) -
Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019) -
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias
por: Schnell, Patrick M, et al.
Publicado: (2021)